Atlas Trials

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

Clinical trial NCT02291887 · COMPLETED

Trial details

NCT number
NCT02291887
Sponsor
Associated Retinal Consultants, Michigan
Status
COMPLETED
Study type
OBSERVATIONAL
Age-Related Macular Degeneration
Start date
2014-12-22
Primary completion
2015-07-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.